Literature DB >> 11834357

Mycophenolate mofetil decreases antibody production after cardiac transplantation.

Marlene L Rose1, John Smith, Georges Dureau, Anne Keogh, Jon Kobashigowa.   

Abstract

New immunosuppressive drugs are extensively being investigated for their effect on T-cell immunity, with far less being known about their effect on the humoral immune response. In view of the experimental and clinical evidence that humoral immunity contributes to acute and chronic rejection, we investigated post-transplant production of anti-vimentin and anti-HLA antibodies in 86 patients who were part of a worldwide clinical trial for mycophenolate mofetil in cardiac transplantation. The results demonstrate that patients taking MMF instead of azathioprine generated significantly fewer de novo anti-vimentin antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834357     DOI: 10.1016/s1053-2498(01)00335-7

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  11 in total

1.  Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil.

Authors:  Douglas E Gladstone; Marc G Golightly; Kenneth W Zamkoff
Journal:  Rheumatol Int       Date:  2005-02-10       Impact factor: 2.631

2.  Existence of circulating anti-endothelial cell antibodies after heart transplantation is associated with post-transplant acute allograft rejection.

Authors:  Karla Lehle; Johannes Kroher; Philipp Kolat; Marietta von Süßkind-Schwendi; Christof Schmid; Assad Haneya; Leopold Rupprecht; Stephan Hirt
Journal:  Heart Vessels       Date:  2015-03-28       Impact factor: 2.037

3.  Single-dose daclizumab induction therapy in patients with liver transplantation.

Authors:  Lu-Nan Yan; Wei Wang; Bo Li; Shi-Chun Lu; Tian-Fu Wen; Qi-Yuan Lin; Yong Zeng; Nan-Sheng Cheng; Ji-Chun Zhao; Yue-Meng Dai
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

4.  Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients.

Authors:  Aránzazu Caballero-Marcos; Magdalena Salcedo; Roberto Alonso-Fernández; Manuel Rodríguez-Perálvarez; María Olmedo; Javier Graus Morales; Valentín Cuervas-Mons; Alba Cachero; Carmelo Loinaz-Segurola; Mercedes Iñarrairaegui; Lluís Castells; Sonia Pascual; Carmen Vinaixa-Aunés; Rocío González-Grande; Alejandra Otero; Santiago Tomé; Javier Tejedor-Tejada; José María Álamo-Martínez; Luisa González-Diéguez; Flor Nogueras-Lopez; Gerardo Blanco-Fernández; Gema Muñoz-Bartolo; Francisco Javier Bustamante; Emilio Fábrega; Mario Romero-Cristóbal; Rosa Martin-Mateos; Julia Del Rio-Izquierdo; Ana Arias-Milla; Laura Calatayud; Alberto A Marcacuzco-Quinto; Víctor Fernández-Alonso; Concepción Gómez-Gavara; Jordi Colmenero; Patricia Muñoz; José A Pons
Journal:  Am J Transplant       Date:  2021-04-27       Impact factor: 9.369

Review 5.  Postoperative care of the transplanted patient.

Authors:  Kurt R Schumacher; Robert J Gajarski
Journal:  Curr Cardiol Rev       Date:  2011-05

Review 6.  Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.

Authors:  Susan Yung; Desmond Yh Yap; Tak Mao Chan
Journal:  F1000Res       Date:  2017-06-13

Review 7.  Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

Authors:  Tulio B Abud; Antonio Di Zazzo; Ahmad Kheirkhah; Reza Dana
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

8.  Comparison of MMF with prednisone in terms of rejection and duration of activity of transplant in rabbits that underwent retroperitoneal heterotopic heart transplantation.

Authors:  Faith Aygün; Duran Efe; Kadir Durgut
Journal:  Cardiovasc J Afr       Date:  2015 May-Jun       Impact factor: 1.167

Review 9.  Role of anti-vimentin antibodies in allograft rejection.

Authors:  Marlene L Rose
Journal:  Hum Immunol       Date:  2013-06-15       Impact factor: 2.850

Review 10.  A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies.

Authors:  Tineke Kardol-Hoefnagel; Henny G Otten
Journal:  Transplantation       Date:  2021-07-01       Impact factor: 5.385

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.